Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Drug company (FDA labeler)

Accord BioPharma Inc.

NDC labeler code: 69448

What is a labeler?

The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.

Official FDA data only

Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.

Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.

At a glance

16Products (NDC)

Prescription medicines

FDA applications for these products

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
  • BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
ApprovedApplicationMedicineSponsor
January 15, 2026BLA761027 Filgrastim
FILKRI
Accord Biopharma Inc.
October 29, 2025BLA761424 Denosumab
JUBEREQ, OSVYRTI
Accord Biopharma Inc.
October 10, 2024BLA761364 Ustekinumab-srlf
IMULDOSA
Accord Biopharma Inc.
April 25, 2024BLA761346 Trastuzumab-strf
HERCESSI
Accord Biopharma Inc.
May 25, 2021NDA211488 Leuprolide
CAMCEVI KIT
Accord
November 2, 2018BLA761039 Pegfilgrastim-cbqv
UDENYCA
Coherus Biosciences Inc
April 30, 1998ANDA064144 Mitomycin
MITOMYCIN
Accord Hlthcare

The sponsor is the company that holds the FDA application; it can differ from the labeler.

Recall timeline

2026

  1. June 10, 2026 · Class II · Ongoing · D-0653-2026 · Ustekinumab-srlf

    Lack of assurance of Sterility:

    IMULDOSA, (ustekinumab-srlf) Injection, 130 mg/26 mL (5mg/mL), Rx only, Single dose vial, Manufactured by Accord BioPharma Inc., 8041 Arco corporate Drive, Suite 200, Raleigh, NC 27617, USA, Manufactured at: Catalent Ind

  2. January 16, 2026 · Class I · Ongoing · D-0353-2026 · Pegfilgrastim-cbqv

    Temperature Abuse. 116 cartons with specific serial numbers of Lot 2199821, were stored incorrectly in a controlled room temperature environment instead of the required refrigerated environment.

    UDENYCA, pegfilgrastim-cbqv injection, 6 mg/0.6mL Single Dose Prefilled Syringe, Rx only, Manufactured by Accord BioPharma, Inc., 8041 Arco Corporate Drive, Suite 200, Raleigh, NC 27617, NDC 69448-025-63

What do the recall classes mean?

Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026

FDA Enforcement Report search → · Report an error →